Post-Operative Opioid-Free Pain Management

  • Multi-billion dollar post-operative pain management opportunity
  • Pre-clinical studies in progress

InSitu Biologics is currently in the investigational pre-clinical stage.
INSB200 is not yet for sale in any geography.

InSitu Biologics is an emerging biotech company focusing on development of INSB200, an opioid-free long-lasting product for post-op pain control. Using disruptive technology to address an unmet need, InSitu’s mission is to avoid exposing surgical patients to opioids. INSB200 is a single-injection nerve block containing the anesthetic ropivacaine that has pain-killing efficacy to 72+ hours.